Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview
with Shay
Schnet,CEO and Director, Mark Krytiuk,
President and Chairman of Nabis Holdings Inc. (CSE: $NAB.C) (OTC:
$NABIF)
Delta, Kelowna, BC –September 19, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/09191Interview-CSENAB.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast I interview Shay Schnet,
the CEO and Director, as well as Mark Krytiuk,
the President and Chairman of the Board of Nabis
Holdings Inc. (CSE: NAB) (OTC: NABIF), where we discussed the importance of
compliance and EU GMP facilities in the U.S. market as well as the cannabis
industry as a whole.
Shay has over 20 years of business
experience and was most recently a founding partner and Vice President of
Operations at MPX Bioceutical Corporation. Shay spent the last 5 years of his
career focused on the North American cannabis space and helped to build MPX’s
portfolio of international cannabis assets.
Mark is a successful cannabis operator
and was a founding partner of MPX. Mark has over 5 years of experience as the
Vice President of Grow Operations for MPX overseeing the production of medical
marijuana and pharma-grade products across North America.Mark has been directly
involved in the rapid expansion and growth of nine facilities in three
different countries, with budgets up to $30 million.
Both made their names known in the
industry as the co-founders of MPX Bioceutical, one of the largest takeover
offers in U.S. Cannabis to date with the MPX merger with iAnthus for $835M CAD.
When
asked about the importance of vertical integration in the U.S. markets, Mark
commented, “there’s a reason for it, especially in the U.S. You can’t cross
state lines, or import cannabis or export cannabis, so you have to be able to
control everything in that manufacturing process. There are certain states
where there is an abundance of cultivation, and we are able to team up with
cultivators and purchase their product at set rates. You’ll see that in
Washington, California and Oregan where there’s an abundance of cultivation.
Our beliefs are always based around GMP quality and standards and to be able to
bring it to a higher standard than what you currently see in the U.S. Canada,
even though the number of SKUs that are allowed to be released are very
limited, they have set the bar very high with very high standards. If you see
what’s happening in Europe, you have to be EU GMP. Unfortunately, the U.S. has
not caught up to GMP, or almost pharma grade standards.”
When
asked about the companies focus on the U.S. market and how this compared to
other international markets coming online Mark commented, “It is the world’s
largest market. I think all of Australia has about 5,000 patients, compared to
just the state of Michigan which has over
350,000 patients. We still have a strong belief that not only is the U.S.
market the largest in the world, but it still has huge upside potential. It’s
still a market where you can’t cross state lines and you don’t have federal
banking, so there’s still a lot of changes coming to the market. By us thinking
that the standard will come up to be GMP, and everyone will have to come to
that standard at some time, for us we can just go to work immediately.”
Adding
on to that and discussing what makes Nabis stand out in this market, Shay
commented, “What we’re doing different is the GMP. You’re not seeing a lot of
the MSO’s really looking at it. By doing GMP right off the bat, we are helping
create the standards and staying above the regulations, knowing they’re coming.
We really looked at California for inspiration. As soon as they introduced
proper regulations into the market you had about 70% of the products drop off
immediately. Right now you’re just seeing some of the bigger brands come back
online, and some of them died off completely and some survived. We know that
that’s going to carry across the nation and we’re just staying ahead of the
curve.”
When
discussing potential federal legalization in the U.S. and how this may affect
the U.S. cannabis market, Shay commented, “It’s not a beneficial factor (for
MSOs) at this point for federal legalization. Even when legalization comes in,
there will still be some State laws. I think you’re a long away from where
California will allow Washignton product to come in. I think federal
legalization won’t really solve too much at this point. As it becomes more real
you’ll have to focus on the branding and the products.”
Shay
added, “I would definitely agree with what Shay just said. If you’re a
cultivator in Washington and now someone can show up and build a million square
foot mega facility, you’re going to be hard pressed to be able to compete for
price at that point. In saying that we don’t build huge mega facilities, we
build small micro GMP facilities. I would also agree with the fact that whether
it’s federally legal or not, the state will not allow their license to be able
to import from another state. The revenues and the jobs are going to be kept in
that state because you still need to cultivate, process and retail it in that
state.”
Nabis
Holdings Inc. has been active in the last month having announced
the acquisition of a cultivation,
production and fulfillment facility located in Camp Verde, Arizona near
Phoenix, making this the second announced acquisition for Nabis in the state of
Arizona following its definitive agreement to acquire a licensed medical
marijuana business including a Phoenix dispensary.
The company also launched BIS
(Be In Synergy), its new exclusive brand of cannabidiol (“CBD”) product lines
as well as announced
entering into a strategic agreement with CannaKorp, Inc. (“CannaKorp”), a
Massachusetts-based technology start-up company that is simplifying and
improving the experience for herbal vaporization, to be an authorized partner
manufacturing and supplying Wisp Pods to be used in CannaKorp’s innovative Wisp Vaporizing System
(“Wisp”) in the state of Arizona. The Company will supply custom Wisp Pods
branded as BIS, the
Company’s recently launched cannabidiol (“CBD”) brand.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment